Harrow Health Inc (NASDAQ:HROW)
| 6.52 Delayed Data As of 4:00pm ET |  +0.04 / +0.62%Today’s Change | 4.10 Today|||52-Week Range 8.99 | +14.59% Year-to-Date |
Latest HROW News | Press Releases
No recent news for Harrow Health Inc.
Today’s Trading
| Previous close | 6.48 |
| Today’s open | 6.46 |
| Day’s range | 6.46 - 6.77 |
| Volume | 87,264 |
| Average volume (3 months) | 220,089 |
| Market cap | $163.1M |
Data as of 4:00pm ET, 12/09/2019
Growth & Valuation
| Earnings growth (last year) | -- |
| Earnings growth (this year) | -114.75% |
| Earnings growth (next 5 years) | +15.00% |
| Revenue growth (last year) | +54.52% |
| P/E ratio | 9.7 |
| Price/Sales | 3.27 |
| Price/Book | 6.37 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| EYPTEyePoint Pharmaceuti... | -0.02 | -1.33% |
| KLDOKaleido Biosciences ... | -0.13 | -2.43% |
| ACSTAcasti Pharma Inc | -0.01 | -0.54% |
| IDYAIDEAYA Biosciences I... | -0.22 | -2.86% |
Data as of 4:00pm ET, 12/09/2019
Financials
| Next reporting date | March 11, 2020 |
| EPS forecast (this quarter) | $0.01 |
| Annual revenue (last year) | $41.4M |
| Annual profit (last year) | $14.6M |
| Net profit margin | 35.35% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Other |
No executives to display |
Corporate headquarters San Diego, California |
Forecasts
